NACE-ABC REGIONAL PROGRAMS: Emerging Challenges in Primary Care 2019 – Denver, CO
Saturday, August 10, 2019
Sheraton Denver Tech Center
7007 S. Clinton Street
Greenwood Village, CO 80112
(303)799-6200
Registration Fee
There is no registration fee for this activity.
Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.
Event Parking
Complimentary self-parking is available at the hotel.
Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.
We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.
Please join us and become an active participant in this one-day learning community of your peers.
Learning Objectives
At the conclusion of this program, participants should be able to:
At the conclusion of this program, participants should be able to:
Recognize the risk for, and impact of, hypoglycemia in patients with diabetes; Integrate strategies to reduce the risk of glycemic variability into the care of patients with diabetes; Recognize how to use SMBG or newer CGM devices to reduce the risk of dysglycemia/hypoglycemia; Differentiate between available insulin preparations and their effects on glycemic variability and hypoglycemic risk.
Learn when clinical symptoms are indicative of functional disorders rather than disease; Become familiar with ongoing endocrine disorders in primary care patients; Understand pituitary function in health and disease; Differentiate among adrenal disorders of hypo and hyperfunction; Successfully treat “symptomatic” thyroid patients.
Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.
Recognize the association between hypertriglyceridemia and atherosclerotic cardiovascular disease (ASCVD); Discuss the different biologic properties of omega-3 fatty acids and their impact on lipid levels; Identify patients who might benefit from triglyceride lowering; Utilize evidence-based approaches to manage patients with hypertriglyceridemia.
Outline the role of medications in treating Opioid Use Disorder (OUD); Outline the role of non-pharmacologic approaches in treating OUD; Discuss integration of medications and non-pharmacologic approaches in OUD; Discuss aspects of patient engagement in treating OUD.
Agenda*
| 7:30-8:00 am | Continental Breakfast and Registration |
| 8:00-8:10 | Welcome Remarks – Marlene Wolf, MD |
| 8:10-9:20 | Insulin Therapy and Glycemic Variability: Strategies for Achieving Diabetes Goals While Minimizing Hypoglycemia Mark Stolar, MD |
| 9:20-10:30 | Primary Care Endocrinology: The Common and Not So Common Mark Stolar, MD |
| 10:30-10:50 | Break |
| 10:50-12:00 pm | A Case Based Approach to Lipids Management: Individualizing Targets and Reducing Risk Robert L. Gillespie, MD, FACC, FASE, FASNC |
| 12:00-1:10 | Lunch (on your own) |
| 1:10-2:20 | Cardiovascular Disease and Hypertriglyceridemia: The Evolving Link Robert L. Gillespie, MD, FACC, FASE, FASNC |
| 2:20-3:30 | Multimodal Treatment for Persons with Opioid Use Disorder Steven Wright, MD |
| 3:30-3:45 | Summary of Key Points and Closing Remarks |
* Agenda subject to change
Faculty
Robert L. Gillespie, MD, FACC, FASE, FASNC
Past Chairman of the Board
Association of Black Cardiologists
Director of Nuclear Imaging
Sharp Rees-Stealy Medical Group
San Diego, CA
Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL
Steven Wright, MD
Family Medicine
Addiction Medicine, Board Certified
Medical Pain Management
Lakewood, CO
Moderator
Marlene R. Wolf, MD, FAAFP
Clinical Assistant Professor of Family Medicine
Nova Southeastern University’s College of Allopathic Medicine
Family Practice
Lifetime Medical Consulting, LLC
Coral Springs, FL
Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL
Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education
Plantation, FL
Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education
Plantation, FL
Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY
Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA
Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA
Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6.0 Contact hour(s) of continuing education, which includes 3.0 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information will be provided in the activity materials.
Commercial Support
This activity is supported by educational funding provided by Amgen.